The following constitutes a breach subject to a financial penalty: 1° Distributing or transferring gene therapy preparations or xenogenic cell therapy preparations, whether free of charge or for consideration, without authorisation or when the authorisation is suspended or withdrawn; 2° Preparing, storing, distributing, transferring, importing or exporting gene therapy preparations or xenogenic cell therapy preparations without complying with the rules of good practice defined in the decisions or orders issued…